人工智能时代的胃肠病学:桥接技术与临床实践。

IF 5.4 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Yagna Mehta, Saumya Mehta, Vishwa Bhayani, Sankalp Parikh, Rajiv Mehta
{"title":"人工智能时代的胃肠病学:桥接技术与临床实践。","authors":"Yagna Mehta, Saumya Mehta, Vishwa Bhayani, Sankalp Parikh, Rajiv Mehta","doi":"10.3748/wjg.v31.i36.110549","DOIUrl":null,"url":null,"abstract":"<p><p>The integration of artificial intelligence (AI), deep learning (DL), and radiomics is rapidly reshaping gastroenterology and hepatology. Advanced computational models including convolutional neural networks, recurrent neural networks, transformers, artificial neural networks, and support vector machines are revolutionizing both clinical practice and biomedical research. This review explores the broad applications of AI in managing patient data, developing disease-specific algorithms, and performing literature mining. In drug discovery, AI-driven computational chemistry is significantly speeding up drug discovery and development by accelerating hit identification, lead optimization, and formulation development. Machine learning models enable the precise prediction of molecular interactions and drug-target binding, thereby improving screening efficiency and reducing reliance on conventional experimental methods. AI also plays a central role in structure-based drug design, molecular docking, and absorption, distribution, metabolism, excretion, and toxicity simulations, while facilitating excipient selection and optimizing formulation stability and bioavailability. In clinical endoscopy, DL-enhanced computer vision is advancing ambient intelligence by enabling real-time image interpretation and procedural guidance. AI-based predictive analytics further support personalized medicine by forecasting treatment response in inflammatory bowel disease. Remote monitoring systems powered by AI are proving vital in managing high-risk populations, including patients with acute-on-chronic liver failure, liver transplant recipients, and individuals with cirrhosis requiring individualized diuretic titration. Despite its promise, AI potential in gastroenterology faces challenges stemming from data inconsistencies, ethical concerns, algorithmic biases, and data privacy issues including health insurance portability and accountability act and general data protection regulation compliance. Establishing standardized protocols for data collection, labeling, and sharing, alongside robust multicenter databases and regulatory oversight, are essential for ensuring safe, ethical, and effective AI integration into clinical workflows.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"31 36","pages":"110549"},"PeriodicalIF":5.4000,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476661/pdf/","citationCount":"0","resultStr":"{\"title\":\"Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice.\",\"authors\":\"Yagna Mehta, Saumya Mehta, Vishwa Bhayani, Sankalp Parikh, Rajiv Mehta\",\"doi\":\"10.3748/wjg.v31.i36.110549\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The integration of artificial intelligence (AI), deep learning (DL), and radiomics is rapidly reshaping gastroenterology and hepatology. Advanced computational models including convolutional neural networks, recurrent neural networks, transformers, artificial neural networks, and support vector machines are revolutionizing both clinical practice and biomedical research. This review explores the broad applications of AI in managing patient data, developing disease-specific algorithms, and performing literature mining. In drug discovery, AI-driven computational chemistry is significantly speeding up drug discovery and development by accelerating hit identification, lead optimization, and formulation development. Machine learning models enable the precise prediction of molecular interactions and drug-target binding, thereby improving screening efficiency and reducing reliance on conventional experimental methods. AI also plays a central role in structure-based drug design, molecular docking, and absorption, distribution, metabolism, excretion, and toxicity simulations, while facilitating excipient selection and optimizing formulation stability and bioavailability. In clinical endoscopy, DL-enhanced computer vision is advancing ambient intelligence by enabling real-time image interpretation and procedural guidance. AI-based predictive analytics further support personalized medicine by forecasting treatment response in inflammatory bowel disease. Remote monitoring systems powered by AI are proving vital in managing high-risk populations, including patients with acute-on-chronic liver failure, liver transplant recipients, and individuals with cirrhosis requiring individualized diuretic titration. Despite its promise, AI potential in gastroenterology faces challenges stemming from data inconsistencies, ethical concerns, algorithmic biases, and data privacy issues including health insurance portability and accountability act and general data protection regulation compliance. Establishing standardized protocols for data collection, labeling, and sharing, alongside robust multicenter databases and regulatory oversight, are essential for ensuring safe, ethical, and effective AI integration into clinical workflows.</p>\",\"PeriodicalId\":23778,\"journal\":{\"name\":\"World Journal of Gastroenterology\",\"volume\":\"31 36\",\"pages\":\"110549\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476661/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3748/wjg.v31.i36.110549\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v31.i36.110549","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

人工智能(AI)、深度学习(DL)和放射组学的融合正在迅速重塑胃肠病学和肝病学。包括卷积神经网络、循环神经网络、变压器、人工神经网络和支持向量机在内的先进计算模型正在彻底改变临床实践和生物医学研究。这篇综述探讨了人工智能在管理患者数据、开发疾病特定算法和进行文献挖掘方面的广泛应用。在药物发现方面,人工智能驱动的计算化学通过加速命中识别、先导优化和配方开发,显著加快了药物发现和开发。机器学习模型能够精确预测分子相互作用和药物靶标结合,从而提高筛选效率,减少对传统实验方法的依赖。人工智能在基于结构的药物设计、分子对接、吸收、分布、代谢、排泄和毒性模拟中也发挥着核心作用,同时促进了辅料的选择,优化了配方的稳定性和生物利用度。在临床内窥镜中,dl增强的计算机视觉通过实现实时图像解释和程序指导,正在推进环境智能。基于人工智能的预测分析通过预测炎症性肠病的治疗反应进一步支持个性化医疗。事实证明,人工智能驱动的远程监测系统对于管理高风险人群至关重要,包括急性慢性肝功能衰竭患者、肝移植受者和需要个体化利尿剂滴定的肝硬化患者。尽管前景光明,但人工智能在胃肠病学领域的潜力面临着来自数据不一致、伦理问题、算法偏见和数据隐私问题(包括健康保险可移植性和问责法案以及一般数据保护法规合规性)的挑战。建立数据收集、标签和共享的标准化协议,以及强大的多中心数据库和监管监督,对于确保将人工智能安全、道德和有效地整合到临床工作流程中至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice.

The integration of artificial intelligence (AI), deep learning (DL), and radiomics is rapidly reshaping gastroenterology and hepatology. Advanced computational models including convolutional neural networks, recurrent neural networks, transformers, artificial neural networks, and support vector machines are revolutionizing both clinical practice and biomedical research. This review explores the broad applications of AI in managing patient data, developing disease-specific algorithms, and performing literature mining. In drug discovery, AI-driven computational chemistry is significantly speeding up drug discovery and development by accelerating hit identification, lead optimization, and formulation development. Machine learning models enable the precise prediction of molecular interactions and drug-target binding, thereby improving screening efficiency and reducing reliance on conventional experimental methods. AI also plays a central role in structure-based drug design, molecular docking, and absorption, distribution, metabolism, excretion, and toxicity simulations, while facilitating excipient selection and optimizing formulation stability and bioavailability. In clinical endoscopy, DL-enhanced computer vision is advancing ambient intelligence by enabling real-time image interpretation and procedural guidance. AI-based predictive analytics further support personalized medicine by forecasting treatment response in inflammatory bowel disease. Remote monitoring systems powered by AI are proving vital in managing high-risk populations, including patients with acute-on-chronic liver failure, liver transplant recipients, and individuals with cirrhosis requiring individualized diuretic titration. Despite its promise, AI potential in gastroenterology faces challenges stemming from data inconsistencies, ethical concerns, algorithmic biases, and data privacy issues including health insurance portability and accountability act and general data protection regulation compliance. Establishing standardized protocols for data collection, labeling, and sharing, alongside robust multicenter databases and regulatory oversight, are essential for ensuring safe, ethical, and effective AI integration into clinical workflows.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信